We may hypothesize that the upregulation of BCL2 in astrocytes during MS may be closely associated to reactive gliosis, that could synergically act in CNS inflammation and demyelination, e.g. in glial scar formation by hypertrophic astrocytes (77). The gene discussed is BCL2; the disease is myeloid sarcoma.